HemoShear Therapeutics, LLC

Industry

  • Biotechnology
    • Drug Discovery Technologies
      • ADMET
  • Pharmaceuticals
See more in Biomedtracker

Latest on HemoShear Therapeutics, LLC

Scrip

Finance Watch: $2.2bn In New Funding Sources In February, So Far

 
• By Mandy Jackson

Halfway through February, seven different sources of funding for health care and life science innovations have announced newly raised pools of cash totaling $2.2bn for a wide array of technologies, in

Scrip

Asia Deal Watch: CStone Partners With LegoChem On Novel ADC Candidate

 
• By Ian Haydock, Anju Ghangurde, Jung Won Shin, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. CStone Gets Global Rights, Except South

Scrip

$1bn Deal Boosts Takeda, Arrowhead’s Liver Disease And RNAi Ambitions

 
• By Ian Haydock

US RNA interference specialist Arrowhead Pharmaceuticals, Inc. has now reached big pharma licensing deals for all three of its most advanced pipeline assets, this time striking an agreement with Ta

Scrip

Asia Deal Watch: Takeda Will Employ Engitix’s ECM Tech In Liver Fibrosis Indications

 
• By Anju Ghangurde, Vibha Ravi, Jung Won Shin, Ian Haydock, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Takeda Seeks Direct Anti-Fibrotic Targe